TUESDAY, April 12, 2022 (HealthDay News) — Immune system-triggered inflammation is the likely reason for the loss of smell reported by many COVID-19 patients, a new study finds. “As a neuropathologist, I wondered why smell loss is a very common symptom with COVID-19 but not with other respiratory diseases,” saidContinue Reading
TUESDAY, April 12, 2022 (HealthDay News) — Even as the COVID-19 pandemic kept people isolated at home, sexually transmitted disease (STDs) cases increased across the United States. Although cases fell in the pandemic’s early months, infections rose again by the end of 2020, with gonorrhea, syphilis and congenital syphilis surpassingContinue Reading
TUESDAY, April 12, 2022 (HealthDay News) — Drug overdose deaths among America’s teens have skyrocketed during the pandemic, and not because drug use is more common, researchers report. In 2020, overdose deaths among adolescents nearly doubled, compared with 10 years before the pandemic. They rose another 20% in the firstContinue Reading
TUESDAY, April 12, 2022 (HealthDay News) — Certain personality traits may make older adults more or less vulnerable to waning memory and thinking skills, a new study suggests. The study, of nearly 2,000 older adults, found that those high on the “conscientious” scale — organized, self-disciplined and productive — wereContinue Reading
TUESDAY, April 12, 2022 (HealthDay News) — Psilocybin — the active component in “magic mushrooms” — may help rewire the brains of people with depression. Psychedelics including psilocybin have shown promise in treating many mental health disorders in recent years, and a new study is among the first to beginContinue Reading
TUESDAY, April 12, 2022 (American Heart Association News) — At their babies’ 20-week ultrasound, Bridget and Jerrid Conway were eager to catch another glimpse of their twin girls. In the exam room, the technician moved the wand over Bridget’s stomach. When she lingered over Twin A, or Sadie as theyContinue Reading
TUESDAY, April 12, 2022 (HealthDay News) — Faced with rising COVID-19 case counts, Philadelphia has announced that it will reinstate an indoor mask mandate next week. City officials announced the change on Monday, as COVID-19 cases have climbed across the country due to the highly transmissible Omicron subvariant known asContinue Reading
TUESDAY, April 12, 2022 (HealthDay News) — An experimental medication for critically ill COVID-19 patients appears to work so well that the drug’s maker announced Monday it has stopped its clinical trial early and will apply for emergency use authorization. The medication, sabizabulin, halved the death rate in COVID-19 patientsContinue Reading
TUESDAY, April 12, 2022 (HealthDay News) — In their search for a drug to prevent Alzheimer’s disease, scientists are taking a look at certain rheumatoid arthritis drugs. Preliminary findings suggest that a type of rheumatoid arthritis drug known as TNF inhibitors may lower dementia risk in rheumatoid arthritis patients whoContinue Reading
New Drug Halves Death Rate in Those With Severe COVID, Maker Claims: An experimental medication for critically ill COVID patients has worked so well that the drug’s maker announced Monday it has stopped its clinical trial early and will apply for emergency use authorization. Read more Philadelphia Becomes First USContinue Reading